Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

NCT01946880 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

102

Enrollment

NIH

Sponsor class

Stopped Slow enrollment.

Conditions

Systemic Lupus Erythematosus
SLE

Interventions

DRUG: Mycophenolate Mofetil
DRUG: Hydroxychloroquine or Chloroquine
DRUG: Prednisone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]